Kiromic BioPharma, Inc. (KRBPQ)
Develops immune cell therapies to treat solid tumors using gamma delta T cells.
$0.00+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-97.5%
The outlook
KRBPQ is trading near its 52-week low at a penny-stock price, with mixed momentum relative to its moving averages. Analyst coverage appears thin or absent. The overall data leans bearish, reflecting the stock's position at the extreme bottom of its recent range.
What’s behind the score
Price trendMixed vs its moving averages
52-week range2% of the way from its 52-week low to high
Market cap
$265
52-wk high
$0.01
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—